CEREBRUS PHARM LTD has a total of 27 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are EHRREHJ BIOFARMA INK, BARTOLOZZI ALESSANDRA and SANTHERA PHARMACEUTICALS SCHWEIZ AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | United Kingdom | 4 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Adams David Reginald | 15 |
#2 | Roffey Jonathan Richard Anthon | 10 |
#3 | Cliffe Ian Anthony | 8 |
#4 | Bentley Jonathan Mark | 8 |
#5 | Mansell Howard Langham | 7 |
#6 | Gaur Suneel | 6 |
#7 | Bodkin Corinna Dagmar | 5 |
#8 | George Ashley Roger | 5 |
#9 | Bebbington David | 5 |
#10 | Monck Nathaniel Julius | 4 |
Publication | Filing date | Title |
---|---|---|
GB9928414D0 | Hydroxypyridone compounds useful in the treatment of oxidative damage to the central nervous system | |
EP1006108A1 | 3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers | |
EP1006112A1 | 3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers | |
GB9925838D0 | Chemical compounds -II | |
GB9925839D0 | Chemical Compounds -I | |
GB9925837D0 | Chemical compounds -III | |
AU2287499A | Azetidinecarboxamide derivatives for treating cns disorders |